iifl-logo-icon 1

ABL Bio-Technologies Ltd Share Price

0.81
(3.85%)
Jul 11, 2016|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

ABL Bio-Technologies Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

0.8

Prev. Close

0.78

Turnover(Lac.)

0.3

Day's High

0.81

Day's Low

0.75

52 Week's High

0

52 Week's Low

0

Book Value

17.21

Face Value

10

Mkt Cap (₹ Cr.)

0.66

P/E

0

EPS

0

Divi. Yield

0

ABL Bio-Technologies Ltd Corporate Action

No Record Found

ABL Bio-Technologies Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

ABL Bio-Technologies Ltd SHAREHOLDING SNAPSHOT

03 Dec, 2024|01:35 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.59%

Foreign: 0.00%

Indian: 0.59%

Non-Promoter- 10.90%

Institutions: 10.89%

Non-Institutions: 88.51%

Custodian: 0.00%

Share Price

ABL Bio-Technologies Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2012Mar-2011Mar-2010Mar-2009

Equity Capital

8.2

8.2

8.2

8.2

Preference Capital

0

0

0

0

Reserves

10.36

10.54

11.13

32.01

Net Worth

18.56

18.74

19.33

40.21

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2012Mar-2011

Revenue

0

0.04

yoy growth (%)

-100

Raw materials

0

-0.07

As % of sales

0

168.76

Employee costs

-0.01

-0.12

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2012Mar-2011

Profit before tax

-0.17

-0.59

Depreciation

-0.06

-0.06

Tax paid

0

0

Working capital

0.07

Other operating items

View Cash Flow
Y/e 31 MarMar-2012Mar-2011

Growth matrix (%)

Revenue growth

-100

Op profit growth

-78.11

EBIT growth

-70.28

Net profit growth

-70.06

View Ratios
Particulars (Rupees in Crores.)Mar-2016Mar-2015Mar-2014Mar-2013Mar-2012

Gross Sales

0

0

0

0

0

Excise Duty

0

0

0

0

0

Net Sales

0

0

0

0

0

Other Operating Income

0.01

0.01

0

0

0

Other Income

0

0

0

0

0

ABL Bio-Technologies Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,808.2

157.374,33,847.75863.290.755,123.6798.33

Divis Laboratories Ltd

DIVISLAB

6,250.2

90.321,65,923.175180.482,302513.62

Cipla Ltd

CIPLA

1,508.1

28.771,21,796.041,178.160.863,969.86360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,338.4

69.061,12,981.554600.842,376222.38

Mankind Pharma Ltd

MANKIND

2,615.3

52.271,04,785.17634.4302,529.74269.23

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT ABL Bio-Technologies Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

K O Isaac

Director

G Subramanian

Director

V M Sankaran Nampoothiri

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

ABL Bio Technologies Limited (ABL) is an India-based biotechnology company. The Company operates in three segments: formulation, research and development and the Docosahexaenoic acid (DHA) project. The Company focuses on discovery, collection of microbes, establishment of compound libraries, discovery of drug and nutrition targets and conducting research and converting the strains/compounds in to deliverable active pharmaceutical products. ABL Biotechnologies was incorporated in the year 1992. ABL is engagaed in identification and commercial extraction of bio-chemicals, predominantly from microbes, that are used as nutritional, cosmetic, pharmaceutical, and industrial intermediates.Companys R&D unit is located at Vishakapatnam that has been recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.Companys microbial metabolites laboratory located at Chennai is focused on evaluating new sources of biochemicals from marine organisms.Company has collaborated with institutions such as the National Facility for Marine Cyanobacteria, Bharathidasan University, Trichy, the National Institute of Oceanography, The Madras University and the Dr.A.L.M Post Graduate Institute of Medical Sciences, Madras to introduce joint development programmes of advanced research in India.Company has taken various initiatives such as sale or licensing of technologies, development of biochemical intermediates, conducting research on aquatic
Read More

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp